EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieOpen Access · CC BY 4.0

Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation

Tizian Rosenstock, Thomas Picht, Melina Engelhardt, Ulrike Grittner, Maximilian Mönch, Peter Vajkoczy, José Pedro Lavrador, Ana Mirallave-Pescador, Francesco Vergani, Maximilian Schwendner, Axel Schroeder, Leonie Kram und 6 weitere

Journal of Neuro-Oncology · 2025

DOI: 10.1007/s11060-024-04931-9 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Neuro-Oncology, 2025. Verfasst von Tizian Rosenstock und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berli…. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Brain Neoplasms, Paresis, Postoperative Complications. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medizinische Fakultät Heidelberg der Universität Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objectives Recently, reduction of transcallosal inhibition by contralateral navigated repetitive transcranial magnetic stimulation (nrTMS) improved neurorehabilitation of glioma patients with new postoperative paresis. This multicentric study examines the effect of postoperative nrTMS in brain tumor patients to treat surgery-related upper extremity paresis.

Methods

This is a secondary analysis of two randomized and three one-arm studies in brain tumor patients with new/progressive postoperative paresis. Patients underwent either low frequency contralesional nrTMS or sham stimulation followed by physiotherapy. Outcome was assessed on postoperative day 1, 7, and after 3 months using British Medical Research Council score (BMRC), Fugl-Meyer assessment (FMA), Karnofsky Performance Scale (KPS) and National Institutes of Health Stroke Scale (NIHSS).

Results

A total of 135 patients (mean age of 53.8 years, 60 women) were included, of whom 51 patients were treated in RCTs (30 treatment group, 21 sham group) and 84 in prospective, single-arm studies. Linear mixed models showed an advantage for the treatment group for the BMRC (7 days: OR 3.28; 95%CI: 1.08–9.99; 3 months: OR 2.03, 95%CI: 0.65–6.39) and KPS (7 days: mean difference (MD) 11, 95%CI: 2–19; 3 months: MD 11, 95%CI: 2–20), less pronounced for the FMA (7 days: MD 0.28, 95%CI: -0.34-0.9; 3 months: MD 0.14, 95%CI: -0.52-0.81). A stronger treatment effect was evident with proven ischemia on the postoperative MRI. To observe an improvement by at least one grade at 3 months, the number needed to treat (NNT) for the entire cohort is 4 (BMRC) and 3 patients (KPS), respectively.

Conclusion

Our multicenter data confirm the positive treatment effect of nrTMS to reduce transcallosal inhibition with a considerably low NNT - especially if caused by ischemia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Magnetic StimulationBrain NeoplasmsParesisPostoperative ComplicationsNeurosurgical ProceduresHumansFemaleMiddle AgedMaleAgedAdultTreatment Outcome

Stichwörter der Autor:innen

GliomaNavigated transcranial magnetic stimulation (nTMS)Paresis

Autor:innen und Institutionen

  • Department of Neurosurgery, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • BIH Charité Digital Clinician Scientist Program, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Charitéplatz 1, 10117, Berlin, Germany.
  • Cluster of Excellence: "Matters of Activity. Image Space Material, " Humboldt University, Unter den Linden 6, 10099, Berlin, Germany.
  • Einstein Center for Neurosciences, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, 10117, Berlin, Germany.
  • Institute of Biometry and Clinical Epidemiology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health, Charitéplatz 1, 10117, Ber…
  • Neurosurgical Department, King's College Hospital Foundation Trust, London, UK.

Förderung

  • Medizinische Fakultät Heidelberg der Universität Heidelberg

Zitieren

APA

Rosenstock, T., Picht, T., Engelhardt, M., Grittner, U., Mönch, M., Vajkoczy, P., Lavrador, J. P., Mirallave-Pescador, A., Vergani, F., Schwendner, M., Schroeder, A., Kram, L., Zhang, H., Prabhu, S., Prinsloo, S., Meyer, B., Ille, S., & Krieg, S. M. (2025). Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04931-9

Vancouver

Rosenstock T, Picht T, Engelhardt M, Grittner U, Mönch M, Vajkoczy P, et al. Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation. Journal of Neuro-Oncology. 2025. doi:10.1007/s11060-024-04931-9

BibTeX
@article{Rosenstock2025,
  author = {Rosenstock, Tizian and Picht, Thomas and Engelhardt, Melina and Grittner, Ulrike and Mönch, Maximilian and Vajkoczy, Peter and Lavrador, José Pedro and Mirallave-Pescador, Ana and Vergani, Francesco and Schwendner, Maximilian and Schroeder, Axel and Kram, Leonie and Zhang, Haosu and Prabhu, Sujit and Prinsloo, Sarah and Meyer, Bernhard and Ille, Sebastian and Krieg, Sandro M},
  title = {Improving postsurgical paresis in brain tumor patients by transcranial magnetic stimulation},
  journal = {Journal of Neuro-Oncology},
  year = {2025},
  doi = {10.1007/s11060-024-04931-9}
}
Kostenlos starten →